Melanin Affinity of Xenobiotics

References

• Barbeau A., Dallaire L., Buu N. T., Veilleux F., Boyer H., de Lanney L. E., Irwin I., Langston E. B., Langston J. W. New amphibian models for the study of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Life Sci 1985; 36: 1125–1134
   Google Scholar
• Barbeau A., Dallaire L., Buu N. T., Poirier J., Rucinska E. Comparative behavioral, biochemical and pigmentary effects of MPTP, MPP+ and paraquat in Rana pipiens. Life Sci 1985; 37: 1529–1538
   PubMedGoogle Scholar
• Barden H., Levine S. Histochemical observations on rodent brain melanin. Brain Res Bull 1983; 10: 847–851
   Google Scholar
• Bruenger F. W., Stover B. J., Atherton D. R. The incorporation of various metal ions into in vivo - and in vitro-produced melanin. Radiat Res 1967; 37: 1–12
   Google Scholar
• Burns R. S., Chiueh C. C., Markey S. P., Ebert M. H., Jacobowitz D. M., Kopin I. J. A primate model of parkinsonism: Selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Proc Natl Acad Sci USA 1983; 80: 4546–4550
   PubMed Web of Science ®Google Scholar
• Chiueh C. C., Markey S. P., Burns R. S., Johannessen J., Jacobowitz D. M., Kopin I. J. N-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine, a parkinsonian syndrome causing agent in man and monkey, produces different effects in guinea pig and rat. Pharmacologist 1983; 25: 131
   Google Scholar
• Christensen E., Moller J., Faurbye A. Neuropathological investigation of 28 brains from patients with dyskinesia. Acta Psychiatr Scand 1970; 46: 14–23
   PubMed Web of Science ®Google Scholar
• Cotzias G. C., Papavasiliou P. S., van Woert M. H., Sakamoto A. Melanogenesis and extrapyramidal diseases. Fed Proc 1964; 23: 713–718
   PubMedGoogle Scholar
• D'Amato R. J., Lipman Z. P., Snyder S. H. Selectivity of the parkinsonian neurotoxin MPTP: Toxic metabolite MPP+ binds to neuromelanin. Science 1986; 231: 987–989
   PubMed Web of Science ®Google Scholar
• Das K. C., Abramson M. B., Katzman R. Neuronal pigments: spectroscopic characterization of human brain melanin. J Neurochem 1978; 30: 601–606
   Google Scholar
• Davis G. C., Williams A. C., Markey S. P., Ebert M. H., Caine E. D., Reichert C. M., Kopin I. J. Chronic parkinsonism secondary to intravenous injection of meperidine analogues. Psychiatry Res 1979; 1: 249–254
   PubMed Web of Science ®Google Scholar
• Dencker L., Lindquist N. G. Distribution of labelled chloroquine in the inner ear. Arch Otolaryngol 1975; 101: 185–188
   PubMed Web of Science ®Google Scholar
• Felix C. C., Hyde J. S., Sarna T., Sealy R. C. Interactions of melanin with ions. Electron spin resonance evidence for chelate complexes of metal ions with free radicals. J Am Chem Soc 1978; 100: 3922–3926
   Web of Science ®Google Scholar
• Forrest F. M., Forrest I. S., Roizin I. Clinical and biochemical and postmortem studies on a patient treated with chlorpromazine. Agressologie 1963; 4: 259–265
   Google Scholar
• Greiner A. C., Berry K. Skin pigmentation and corneal and lens opacities with prolonged chlorpromazine therapy. Can Med Assoc J 1964; 90: 663–665
   PubMed Web of Science ®Google Scholar
• Gupta S. K., Murphy R. C., Chandra S. V. Neuromelanin in manganese-exposed primates. Toxicol Lett 1980; 6: 17–20
   PubMed Web of Science ®Google Scholar
• Hallman H., Olson L., Jonsson G. Neurotoxicity of the meperidine analogue N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on brain catecholamine neurons in the mouse. Eur J Pharmacol 1984; 97: 133–136
   Google Scholar
• Heikkila R. E., Hess A., Duvoisin R. C. Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine in mice. Science 1984; 224: 1451–1453
   PubMed Web of Science ®Google Scholar
• Kemali M., Gioffré D. Anatomical localisation of neuromelanin in the brains of the frog and tadpole. Ultrastructural comparison of neuromelanin with other melanins. J Anat 1985; 142: 73–85
   Google Scholar
• Langston J. W., Ballard P., Tetrud J. W., Irwin I. Chronic parkinsonism in humans due to a product of meperidine analog synthesis. Science 1983; 219: 979–980
   PubMed Web of Science ®Google Scholar
• Langston J. W., Forno L. S., Rebert C. S., Irwin I. Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) in the squirrel monkey. Brain Research 1984; 292: 390–394
   PubMed Web of Science ®Google Scholar
• Larsson B. Mechanisms of accumulation of foreign substances in melanin. Binding to preformed melanin and incorporation into growing melanin. Acta Universitatis Upsaliensis 1979; 43
   Google Scholar
• Larsson B., Tjälve H. Studies on the mechanism of drug-binding to melanin. Biochem Pharmacol 1979; 28: 1181–1187
   PubMed Web of Science ®Google Scholar
• Lindquist N. G. Accumulation in vitro of 35-chlorpromazine in the neuromelanin of human substantia nigra. Arch Int Pharmacodyn Ther 1972; 200: 190–195
   PubMedGoogle Scholar
• Lindquist N. G., Ullberg S. The melanin affinity of chloroquine and chlorpromazine studied by whole body autoradiography. Acta Pharmacol Toxicol (Copenh) 1972; 31(Suppl 2)
   Google Scholar
• Lindquist N. G. Accumulation of drugs on melanin. Acta Radiol (Diagn) (Stockh) Suppl 1973; 325
   Google Scholar
• Lindquist N. G., Lyden-Sokolowski A., Larsson B. S. Accumulation of a parkinsonism inducing neurotoxin in melanin-bearing neurons: Autoradiographic studies on 3-MPTP. Acta Pharmacol Toxicol (Copenh) 1986; 59: 161–164
   Google Scholar
• Lydén A., Larsson B., Lindquist N. G. Studies on the melanin affinity fo haloperidol. Arch Int Pharmacodyn Ther 1982; 259: 230–234
   Google Scholar
• Lydén A., Bondesson U., Larsson B. S., Lindquist N. G. Melanin affinity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine, an inducer of chronic parkinsonism in humans. Acta Pharmacol Toxicol (Copenh) 1983; 53: 429–432
   Google Scholar
• Lydén A., Larsson B. S., Lindquist N. G. Melanin affinity of manganese. Acta Pharmacol Toxicol (Copenh) 1984; 55: 133–138
   PubMedGoogle Scholar
• Lydén A., Bondesson U., Larsson B. S., Lindquist N. G., Olsson L.-I. Autoradiography of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): Uptake in the monoaminergic pathways and in melanin containing tissues. Acta Pharmacol Toxicol (Copenh) 1985; 57: 130–135
   Google Scholar
• Mardsen C. D. Brain melanin. Pigments in pathology, M. Wollman. Academic Press, New York 1969; 395–420
   Google Scholar
• Mena I., Mann O., Fuenzalida S., Cotzias C. Chronic manganese poisoning. Clinical picture and manganese turnover. Neurology (NY) 1967; 17: 128–136
   PubMed Web of Science ®Google Scholar
• Potts A. M. The concentration of phenothiazines in the eye of experimental animals. Invest Ophthalmol Vis Sci 1962; 1: 522–530
   Google Scholar
• Potts A. M. The reaction of uveal pigment in vitro with polycyclic compounds. Invest. Ophthalmol Vis Sci 1964; 3: 405–416
   Web of Science ®Google Scholar
• Roizin L. Chemogenic lesions: A multifactor pathogenic concept. Neurotoxicology, L. Roizin, H. Shirakt, N. Grcevic. Raven Press, New York 1977; 613–648
   Google Scholar
• Ullberg S. Studies on the distribution and fate of 35S-labelled benzylpenicillin in the body. Acta Radiol. (Diagn) (Stockh) Suppl 1954; 118: 1–110
   PubMedGoogle Scholar
• Ullberg S. The technique of whole body autoradiography. Cryosectioning of large specimens. Science Tools (The LKB Instrument J.) 1977; 2–29
   Google Scholar